Design of anti-AIDS drugs
著者
書誌事項
Design of anti-AIDS drugs
(Pharmacochemistry library, v. 14)
Elsevier , Distributors for the U.S. and Canada, Elsevier Science Pub. Co, 1990
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
There are several steps in the replicative cycle of human immunodeficiency virus (HIV) that could be considered as adequate targets for chemotherapeutic intervention, e.g., virus attachment to the cells, virus penetration and uncoating, transcription of the viral (RNA) genome to proviral DNA, integration of the proviral DNA into host cell DNA, transcription of the proviral precursor proteins to mature viral proteins, assembly and release ('budding') of the viral particles. These processes depend on, and are regulated by, specific viral proteins. This makes many of these processes and proteins plausible targets for the design of selective inhibitors. The contributions assembled in this book are aimed at presenting what is known anno 1990 about (1) the different steps in the HIV replicative cycle that could be considered as targets for anti-HIV agents, (2) the compounds that interact with these targets and offer promise as candidate drugs for the treatment of HIV infection, and (3) to the extent that it has been resolved, the mechanism of interaction of the anti-HIV agents with their putative targets.
目次
Perspectives for the chemotherapy of HIV infection: An introduction (E. De Clerq). Toward targeted therapy for HIV infection (H. Mitsuya, T. Shirasaka and S. Broder). HIV-CD4 interaction as target for anti-HIV agents (D. Schols and E. De Clerq). Sulfated polymers as inhibitors of HIV replication (M. Baba and E. De Clercq). Potent and selective inhibition of HIV-1 replication in vitro by a novel series of tetrahydro-imidazo [4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione (TIBO) derivatives (R. Pauwels, K. Andries, J. Desmyter, M.J. Kukla, J. Hyekants, E. De Clercq and P.A.J. Janssen). HIV reverse transcriptase as a target for antiviral drugs (K.L. Powell and G. Darby). Dideoxynucleoside analogues as inhibitors of HIV replication (P. Herdewijn and E. De Clercq). Acyclic and carbocyclic nucleoside analogues as inhibitors of HIV replication (J. Balzarini and E. De Clercq). Antisense oligonucleotides as an approach towards anti-AIDS therapy (J.S. Cohen). HIV-1 protease as a target for potential anti-AIDS drugs (T.D. Meek, D.M. Lambert, B.W. Metcalf, S.R. Petteway, Jr. and G.B. Dreyer). Glycoprotein synthesis and human immunodeficiency viruses: A target for chemotherapy (A.S. Tyms, D.L. Taylor, P.S. Sunkara and M.S. Kang). Animal models for anti-AIDS therapy (R.M. Ruprecht). The clinical use of anti-HIV agents (D.D. Richman). Subject index.
「Nielsen BookData」 より